Literature DB >> 30946157

Age-related comorbidities and mortality in people living with HIV in rural Tanzania.

Sascha Albrecht1,2,3, Fabian C Franzeck4, Herry Mapesi1,2,3,5, Christoph Hatz1,2, Aneth Vedastus Kalinjuma3, Tracy R Glass1,2, Dorcas Mnzava3, Emili Letang1,2,3,6, Daniel H Paris1,2, Manuel Battegay4, Maja Weisser1,2,3,4.   

Abstract

OBJECTIVE: Causes of morbidity and mortality of people living with HIV are changing with access to antiretroviral therapy and increased life expectancy. Age-related data on comorbidities and their impact on mortality in sub-Saharan Africa are scarce.
DESIGN: This prospective analysis evaluated comorbidities, assessed by means of International Classification of Diseases and Related Health problems 10th revision codes and clinical variables, derived from data collected from the Kilombero & Ulanga antiretroviral cohort of people living with HIV in rural Tanzania.
METHODS: We calculated prevalences and incidences of comorbidities in patients enrolled from 2013 to 2017 and evaluated their association with a combined endpoint of death and loss to follow-up (LTFU) in various age groups (15-29, 30-49 and ≥50 years) using Cox regression analysis.
RESULTS: Of 1622 patients [65% females, median age 38 years (interquartile range 31-46)], 11% were at least 50 years. During a median follow-up of 22.1 months (interquartile range 10.6-37.3), 48 (2.9%) patients died and 306 (18.9%) were LTFU. Anaemia was the most prevalent comorbidity (66.3%) irrespective of age and was associated with increased mortality/LTFU [hazard ratios 2.02 (95% confidence interval (CI) 1.57-2.60); P < 0.001]. In patients aged at least 50 years, arterial hypertension was highly prevalent (43.8%), but not associated with mortality/LTFU [hazard ratios 1.04 (95% CI 0.56-1.93), P = 0.9]. Undernutrition ranged from 25.5% in the youngest to 29.1% in the oldest age group and contributed to mortality/LTFU [hazard ratios 2.24 (95% CI 1.65-3.04); P < 0.001]. Prevalence of tuberculosis was 21.4% with hazard ratios of 2.54 (95% CI 1.72-3.75, P < 0.001) for mortality/LTFU.
CONCLUSION: We show that anaemia, arterial hypertension and undernutrition are the most relevant comorbidities with different age-associated frequencies and impact on death/LTFU in this population.

Entities:  

Mesh:

Year:  2019        PMID: 30946157     DOI: 10.1097/QAD.0000000000002171

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Prevalence of anaemia and the associated factors among hospitalised people living with HIV receiving antiretroviral therapy in Southwest China: a cross-sectional study.

Authors:  Guiying Cao; Hai Long; Yuedong Liang; Jue Liu; Xiaoxin Xie; Yanhua Fu; Juan He; Su Song; Siqi Liu; Manna Zhang; Yu Wu; Yaping Wang; Min Du; Wenzhan Jing; Jie Yuan; Min Liu
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

2.  Patterns of comorbidity and multimorbidity among middle-aged and elderly women in peri-urban Tanzania.

Authors:  Laura-Marie Stieglitz; Till Bärnighausen; Germana H Leyna; Patrick Kazonda; Japhet Killewo; Julia K Rohr; Stefan Kohler
Journal:  J Multimorb Comorb       Date:  2022-02-22

3.  Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: The prospective Kilombero and Ulanga antiretroviral cohort.

Authors:  Armon Arpagaus; Fabian Christoph Franzeck; George Sikalengo; Robert Ndege; Dorcas Mnzava; Martin Rohacek; Jerry Hella; Klaus Reither; Manuel Battegay; Tracy Renee Glass; Daniel Henry Paris; Farida Bani; Omary Ngome Rajab; Maja Weisser
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

4.  Effect of the Test and Treat Strategy on Mortality Among HIV-Positive Adult Clients on Antiretroviral Treatment in Public Hospitals of Addis Ababa, Ethiopia.

Authors:  Bereket Tesfaye; Dejene Ermias; Sisay Moges; Ayalew Astatkie
Journal:  HIV AIDS (Auckl)       Date:  2021-03-30

5.  The coArtHA trial-identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trial.

Authors:  Thilo Burkard; Maja Weisser; Herry Mapesi; Ravi Gupta; Herieth Ismael Wilson; Blaise Lukau; Alain Amstutz; Aza Lyimo; Josephine Muhairwe; Elizabeth Senkoro; Theonestina Byakuzana; Madavida Mphunyane; Moniek Bresser; Tracy Renée Glass; Mark Lambiris; Günther Fink; Winfrid Gingo; Manuel Battegay; Daniel Henry Paris; Martin Rohacek; Fiona Vanobberghen; Niklaus Daniel Labhardt
Journal:  Trials       Date:  2021-01-21       Impact factor: 2.279

6.  Causes of death and associated factors over a decade of follow-up in a cohort of people living with HIV in rural Tanzania.

Authors:  Getrud Joseph Mollel; Lilian Moshi; Hoda Hazem; Anna Eichenberger; Olivia Kitau; Herry Mapesi; Tracy R Glass; Daniel Henry Paris; Maja Weisser; Fiona Vanobberghen
Journal:  BMC Infect Dis       Date:  2022-01-06       Impact factor: 3.090

7.  Prevalence of anemia among people living with HIV: A systematic review and meta-analysis.

Authors:  Guiying Cao; Yaping Wang; Yu Wu; Wenzhan Jing; Jue Liu; Min Liu
Journal:  EClinicalMedicine       Date:  2022-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.